ALLMedicine™ Diphtheria Center
Research & Reviews 2,237 results
https://doi.org/10.1016/S1473-3099(22)00273-0
The Lancet. Infectious Diseases; Samuels AM, Ansong D et. al.
Jun 27th, 2022 - Controlled infection studies in malaria-naive adults suggest increased vaccine efficacy for fractional-dose versus full-dose regimens of RTS,S/AS01. We report first results of an ongoing trial assessing different fractional-dose regimens in childr...
https://doi.org/10.1016/j.vaccine.2022.06.009
Vaccine Tseng HF, Sy LS et. al.
Jun 19th, 2022 - The objective of this study was to evaluate the safety of prenatal tetanus, diphtheria, acellular pertussis (Tdap) vaccination. This cohort study was conducted among pregnant members at Kaiser Permanente Southern California (KPSC). The exposed coh...
https://doi.org/10.1080/21645515.2022.2044707
Human Vaccines & Immunotherapeutics; Oygar PD, Büyükçam A et. al.
Jun 18th, 2022 - Health care workers (HCWs) are disproportionately exposed to infectious diseases and play a role in nosocomial transmission, making them a key demographic for vaccination. HCW vaccination rates are not optimal in many countries; hence, compulsory ...
https://clinicaltrials.gov/ct2/show/NCT02864368
Jun 9th, 2022 - Patients were enrolled following radiation therapy and prior to initiation of post-radiation therapy cycles of adjuvant TMZ provided they met all eligibility criteria. After signing main consent, patients had immune monitoring blood work collected...
https://clinicaltrials.gov/ct2/show/NCT05237947
Jun 8th, 2022 - PRIMARY OBJECTIVES: I. To evaluate one dose of nonavalent human papillomavirus (HPV) vaccination compared to no vaccination in the protection against incident HPV16/18 cervical HPV infections that persist 6-months or more in women aged 18 to 30 ye...
Guidelines 13 results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004397
MMWR. Morbidity and Mortality Weekly Report; Oliver SE, Moore KL
Feb 7th, 2020 - On December 21, 2018 the Food and Drug Administration (FDA) licensed a hexavalent combined diphtheria and tetanus toxoids and acellular pertussis (DTaP) adsorbed, inactivated poliovirus (IPV), Haemophilus influenzae type b (Hib) conjugate (meningo...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367039
MMWR. Morbidity and Mortality Weekly Report; Havers FP, Moro PL et. al.
Jan 24th, 2020 - Since 2005, a single dose of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine has been recommended by the Advisory Committee on Immunization Practices (ACIP) for adolescents and adults (1,2). After receipt of Tdap,...
https://doi.org/10.1097/AOG.0000000000002665
Obstetrics and Gynecology;
May 26th, 2018 - Immunization is an essential part of care for adults, including pregnant women. Influenza vaccination for pregnant women is especially important because pregnant women who contract influenza are at greater risk of maternal morbidity and mortality ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919600
MMWR. Recommendations and Reports : Morbidity and Mortali... Liang JL, Tiwari T et. al.
Apr 28th, 2018 - This report compiles and summarizes all recommendations from CDC's Advisory Committee on Immunization Practices (ACIP) regarding prevention and control of tetanus, diphtheria, and pertussis in the United States. As a comprehensive summary of previ...
https://doi.org/10.1097/AOG.0000000000002301
Obstetrics and Gynecology;
Aug 24th, 2017 - The overwhelming majority of morbidity and mortality attributable to pertussis infection occurs in infants who are 3 months and younger. Infants do not begin their own vaccine series against pertussis until approximately 2 months of age. This leav...
Drugs 67 results see all →
Clinicaltrials.gov 230 results
https://clinicaltrials.gov/ct2/show/NCT02864368
Jun 9th, 2022 - Patients were enrolled following radiation therapy and prior to initiation of post-radiation therapy cycles of adjuvant TMZ provided they met all eligibility criteria. After signing main consent, patients had immune monitoring blood work collected...
https://clinicaltrials.gov/ct2/show/NCT05237947
Jun 8th, 2022 - PRIMARY OBJECTIVES: I. To evaluate one dose of nonavalent human papillomavirus (HPV) vaccination compared to no vaccination in the protection against incident HPV16/18 cervical HPV infections that persist 6-months or more in women aged 18 to 30 ye...
https://clinicaltrials.gov/ct2/show/NCT03688178
May 27th, 2022 - Human cytomegalovirus (CMV) is a common endemic β-Herpesvirus, and over half of adults have been infected with CMV. CMV does not usually cause significant clinical disease but can cause health problems for people with weakened immune systems. Expr...
https://clinicaltrials.gov/ct2/show/NCT05385042
May 23rd, 2022 - This is a prospective interventional open label cohort study with an exploratory framework. After assessment of gestation by routine ultrasound, women will be invited to participate if they have a viable, singleton pregnancy with a gestation < 28 ...
https://clinicaltrials.gov/ct2/show/NCT05294588
May 20th, 2022 - The study is a single-site, double-blind randomized controlled trial to test whether vaccination with 4C-MenB, BEXSERO™ (approved for protection against invasive disease with group B Neisseria meningitidis), according to the FDA-approved schedule ...
